Validation of a mRNA-based urine test for bladder cancer detection in patients with hematuria von Van Valenberg, F.J.P, Bridge, J.A, Mayne, D, Beqaj, S, Sexton, W.J, Lotan, Y, Weizer, A.Z, Jansz, G.K, Stenzl, A, Danella, J.F, Shepard, B.R, Cline, K.J, Williams, M.B, Montgomery, T, David, R.D, Harris, R.G, Klein, E.W, Bradford, T.J, Wolk, F.N, Westenfelder, K.R, Trainer, A.F, Richardson, T.A, Witjes, J.A

Volltext

Performance characteristics of a mRNA-based urine test for the detection of bladder cancer recurrence von Van Valenberg, F.J.P, Bridge, J.A, Mayne, D, Beqaj, S, Sexton, W.J, Lotan, Y, Weizer, A.Z, Jansz, G.K, Stenzl, A, Danella, J.F, Shepard, B.R, Cline, K.J, Williams, M.B, Montgomery, T, David, R.D, Harris, R.G, Klein, E.W, Bradford, T.J, Wolk, F.N, Westenfelder, K.R, Trainer, A.F, Richardson, T.A, Witjes, J.A

Volltext

863 Low dose GTx-758 decreases free testosterone to levels similar to orchiectomy in men with metastatic castration resistant prostate cancer (mCRPC) von Getzenberg, R.H, Yu, E.Y, Smith, J.A, Hancock, M.L, Tutrone, R, Flaig, T.W, Westenfelder, K.R, Szucs, M, Dalton, J.T, Steiner, M.S

Volltext

117 - Validation of a mRNA-based urine test for bladder cancer detection in patients with hematuria von Van Valenberg, F.J.P., Bridge, J.A., Mayne, D., Beqaj, S., Sexton, W.J., Lotan, Y., Weizer, A.Z., Jansz, G.K., Stenzl, A., Danella, J.F., Shepard, B.R., Cline, K.J., Williams, M.B., Montgomery, T., David, R.D., Harris, R.G., Klein, E.W., Bradford, T.J., Wolk, F.N., Westenfelder, K.R., Trainer, A.F., Richardson, T.A., Witjes, J.A.

Volltext

119 - Performance characteristics of a mRNA-based urine test for the detection of bladder cancer recurrence von Van Valenberg, F.J.P., Bridge, J.A., Mayne, D., Beqaj, S., Sexton, W.J., Lotan, Y., Weizer, A.Z., Jansz, G.K., Stenzl, A., Danella, J.F., Shepard, B.R., Cline, K.J., Williams, M.B., Montgomery, T., David, R.D., Harris, R.G., Klein, E.W., Bradford, T.J., Wolk, F.N., Westenfelder, K.R., Trainer, A.F., Richardson, T.A., Witjes, J.A.

Volltext